Gliclazide API is the active ingredient of a sulfonylurea oral hypoglycemic drug. It mainly reduces blood glucose levels by stimulating the secretion of insulin from pancreatic islet β cells and is suitable for patients with type 2 diabetes. It can effectively control fasting blood glucose and postprandial blood glucose. At the same time, it also has a certain effect of improving microangiopathy, which can reduce the risk of diabetes complications. It is widely used in the drug treatment of diabetes and helps patients maintain stable blood glucose levels for a long time.
-
![Gliclazide CAS NO.21187-98-4]()
Gliclazide CAS NO.21187-98-4Sulfonylurea hypoglycemic agents; membrane transport / ion channels; hormones and endocrine regulatory drugs; pancreatic hormones and other blood glucose regulators DMF
We're well-known as one of the leading gliclazide api manufacturers and suppliers in China. Our factory offers high quality gliclazide api made in China with competitive price. Welcome to contact us for wholesale service.
